Mon panier

CD46

CD46 Informations sur la molécule

Nom anglaisMembrane cofactor proteinNombre de médicaments commercialisés0
Nombre de médicaments cliniques5Alias de la cibleTLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisMembrane cofactor protein
Alias de la cibleTLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques5
Phase de R&D la plus avancéePhase 2 Clinical

CD46 Liste de produits

  • Attribut

    Protein (5)

  • Bibliothèque de produits

    En ligne (5)

  • Espèces

    Human (5)

  • Étiquette

    His Tag (4)Fc Tag (1)

  • Marqueur

    Unconjugated (2)FITC Labeled (1)APC Labeled (1)PE Labeled (1)

CD46Contexte de la molécule

Complement regulatory protein CD46 is also known as membrane Cofactor Protein (MCP), is a type I membrane protein and is a regulatory part of the complement system. CD46 is expressed by all cells except erythrocytes. MCP acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue, and also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. In T-cells by binding to CD46, A number of viral and bacterial pathogens seem to exploit this property and directly induce an immunosuppressive phenotype.

CD46Alias de la molécule

CD46,AHUS2,MCP,MIC10,TLX,TRA2.10

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Anti-CD46 antibody drug conjugate (Fortis Therapeutics)FOR-46; FG-3246Phase 2 ClinicalUniversity Of California San DiegoProstatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms
Details
EnadenotucirevColoAd-1; Oncolytic Ad11/Ad3Phase 1 ClinicalAkamis Bio LtdOvarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Colonic Neoplasms; Neoplasms, Glandular and Epithelial; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
AugmAbBRM-132Phase 1 ClinicalNeoplasms; Lymphoma, Non-Hodgkin
Details
YS-5YS-5Phase 1 ClinicalFortis Therapeutics Inc, United States Department Of DefenseProstatic Neoplasms, Castration-Resistant; Prostatic Neoplasms
Details
FG-318089Zr-DFO-YS-5; 89Zr-DFO-YS5Phase 1 ClinicalFortis Therapeutics IncMultiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques